IP Library Granted Patent US 11,547,651
Granted Patent B2
US 11,547,651 · App. 16/550,122 · Granted Jan 10, 2023

Ecofriendly biofilm-disrupting antimicrobial formulations, their development, and their uses

Inventor: Mitchell Corey Sanders (Grafton, MA)
Assignee: Alira Health Boston LLC
A61K8/73A61K8/731A61K8/733A61K8/87A61K47/34A61K47/36A61K47/38A61Q11/00A61Q19/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,547,651
App. No.
16/550,122
Granted
Jan 10, 2023
Kind
B2
Abstract

A skin care, wound care, or oral care device, comprising an essential oil stabilized into a polymerizable substance.

Claims (15)

1. A skin and wound care device, comprising first and second microcrystallized or microencapsulated essential oils which are broad spectrum antimicrobials polymerized into a polymer.

2. The skin and wound care device of claim 1 , wherein the first and second essential oils are microencapsulated into pectin shells.

3. The skin and wound care device of claim 2 , wherein the microencapsulation takes place in a 1-10% pectin solution.

4. The skin and wound care device of claim 2 , wherein the polymer comprises an alginate polymer.

5. The skin and wound care device of claim 2 , wherein the polymer comprises a polyurethane foam.

6. The skin and wound care device of claim 1 , wherein the polymer comprises cellulose.

7. The skin and wound care device of claim 6 , wherein the cellulose comprises nanocrystalline or microcrystalline cellulose particles.

8. The skin and wound care device of claim 1 , wherein the polymer comprises microcellulose, nanocellulose, alginate, polyurethane, collagen, hyaluronic acid, PEG, silicone, or a silicone acrylic polymer.

9. The skin and wound care device of claim 1 , wherein the first and second microcrystallized or microencapsulated essential oils are mixed into a polymeric material comprising silicone, acrylic, nylon, polylactic acid, polyethylene, polypropylene, Teflon, polystyrene, polyurethane, alginate, PET, or PEEK.

10. The skin and wound care device of claim 1 , comprising a rinse, gel, foam, wound dressing, suture, staple, or wipe.

11. The skin and wound care device of claim 1 , wherein the first and second essential oils are microencapsulated in pectin shells.

12. The skin and wound care device of claim 11 , wherein the first and second essential oils that are microencapsulated in pectin shells are polymerized into alginate polymer.

13. The skin and wound care device of claim 12 , comprising a wound dressing.

14. The skin and wound care device of claim 1 , wherein the first essential oil is cinnamon and the second essential oil is lemongrass.

15. A wound dressing, comprising: first and second essential oils which are broad spectrum antimicrobials microencapsulated into pectin shells, wherein the pectin shells are polymerized into an alginate polymer.

Assignments (1)
SECURITY INTEREST Recorded Oct 23, 2024
From: ALIRA HEALTH BOSTON LLC; ALIRA HEALTH GROUP HOLDINGS LLC; RED CROW CROWD, INC.; FIREFLY INNOVATIONS, LLC; ARTISAN HEALTHCARE CONSULTING, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 068993/0485 →
Continuity (3)
Continuation PCTUS2018019400 · Feb 23, 2018
Provisional Application 62462686 · Feb 23, 2017
Related Publication 20200121582A1 · Apr 23, 2020